What does Nautilus Biotechnology, Inc. do?
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents,…
What is Nautilus Biotechnology, Inc.'s P/E and P/B ratio?
Nautilus Biotechnology, Inc. has a P/E ratio of -5.8 and a P/B ratio of 2.52.
What is Nautilus Biotechnology, Inc.'s debt-to-equity ratio?
Nautilus Biotechnology, Inc. has a debt-to-equity ratio of 0.21.
How much does Nautilus Biotechnology, Inc. owe compared with what it owns?
Nautilus Biotechnology, Inc. owes $0.20 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Nautilus Biotechnology, Inc.'s Positivity rank?
Nautilus Biotechnology, Inc. is ranked #3,216 of 6,775 companies globally and #1,282 of 4,000 in United States on PositoAI, with a Positivity Score of 20,785.
Does Nautilus Biotechnology, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Nautilus Biotechnology, Inc..
Where can I read the latest news about Nautilus Biotechnology, Inc.?
Recent headlines about Nautilus Biotechnology, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Nautilus Biotechnology, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Nautilus Biotechnology, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.